Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers
European Journal of Clinical Pharmacology · 2023-06 · 79 (6) · 775-787
DOI: 10.1007/s00228-023-03477-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 15.04.2023. Verfasst von Angela Elma Edwina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Fosfomycin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
A population pharmacokinetic model of fosfomycin was developed in healthy volunteers after intravenous administration, and different dosing regimens were evaluated in terms of the probability of target attainment for Escherichia coli using both plasma and urinary pharmacokinetic/pharmacodynamic targets.
Methods
Eight healthy men received fosfomycin as both intermittent 8 g q8h and continuous infusion 1 g/h with a loading dose of 8 g in a crossover study design. Dense sampling was conducted during both regimens. Population pharmacokinetic modelling was performed using NONMEM. Monte Carlo simulations were conducted to evaluate the Probability of Target Attainment (PTA) of different dosing regimens using bactericidal (AUC 24h /MIC of 83 and 75% T >MIC ) and bacteriostatic (AUC 24h /MIC of 25) plasma targets and bacteriostatic (AUC 24h /MIC of 3994) urine target.
Results
A total of 176 plasma and 86 urine samples were available for PK analysis. A two-compartment model with a urine compartment best described the data. Glomerular filtration rate (GFR) showed a significant correlation with renal clearance and was implemented in the final model. Simulation results show that the dose of 4 g q8h reached 100% of PTA using bactericidal and bacteriostatic targets for MIC up to 16 mg/L.
Conclusion
For the clinical breakpoint of 32 mg/L, the standard dosing regimen (4 g q8h) might not be sufficient to reach the bactericidal target. Higher dosing of 8 g q8h as an intermittent infusion or 0.75 g/h as a continuous infusion might be required. Continuous infusion resulted in better attainment of the % T >MIC target than intermittent infusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.
- Gerontology and Geriatrics Unit, Department of Public Health and Primary Care, KU Leuven - University of Leuven, Leuven, Belgium.
- Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands.
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Zitieren
APA
Edwina, A. E., Koch, B. C. P., Muller, A. E., Al Jalali, V., Matzneller, P., Zeitlinger, M., & Sassen, S. D. T. (2023). Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers. European Journal of Clinical Pharmacology, 79(6), 775-787. https://doi.org/10.1007/s00228-023-03477-5
Vancouver
Edwina AE, Koch BCP, Muller AE, Al Jalali V, Matzneller P, Zeitlinger M, et al. Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers. European Journal of Clinical Pharmacology. 2023;79(6):775-787. doi:10.1007/s00228-023-03477-5
BibTeX
@article{Edwina2023,
author = {Edwina, Angela Elma and Koch, Birgit C P and Muller, Anouk E and Al Jalali, Valentin and Matzneller, Peter and Zeitlinger, Markus and Sassen, Sebastiaan D T},
title = {Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers},
journal = {European Journal of Clinical Pharmacology},
year = {2023},
volume = {79},
number = {6},
pages = {775--787},
doi = {10.1007/s00228-023-03477-5}
}
EUVIMED